TG THERAPEUTICS, INC. - COMMON STOCK (TGTX)

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COMMON STOCK
Shares outstanding
158,835,667
Total 13F shares
7,133,812
Share change
0
Total reported value
$27,819,201
Price per share
$3.90
Number of holders
41
Value change
$0

Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2013

As of 31 Dec 2013, TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,133,812 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BRIDGER MANAGEMENT, LLC, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, NORTHERN TRUST CORP, Smith Asset Management Group LP, COLUMBUS CIRCLE INVESTORS, State Street Corp, and BlackRock Institutional Trust Company, N.A.. This page lists 42 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.